Gebelik ve Perikardiyal Hastalıklar
Öz
Anahtar Kelimeler
Kaynakça
- 1. Pieper PG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol 2015;12:718–29.
- 2. Haiat R, Halphen C. Silent pericardial effusion in late pregnancy: a new entity. Cardiovasc Intervent Radiol 1984;7:267–9.
- 3. Halphen C, Haiat R, Clément F, et al. Silent pericardial effusion in late pregnancy: echocardiographic detection in the third trimester of pregnancy. J Gynecol Obstet Biol Reprod 1982;11:245–8.
- 4. Vitse M, Lesbre JP, Boulanger JC et al. Our experience of the detection of latent pericardial effusions in the 3rd trimester of pregnancy. Rev Fr Gynecol Obstet 1984;79:765–9.
- 5. Imazio M, Brucato A, Rampello S, Armellino F, Trinchero R, Spodick DH, Adler Y. Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown) 2010;11:557–562.
- 6. Ristić AD, Seferović PM, Ljubić A, et al. Pericardial disease in pregnancy. Herz 2003;28:209–15.
- 7. Forbat LN, Hancock BW, Gershlick AH. Methotrexateinduced peric arditis and pericardial effusion; first reported case. Postgrad Med J 1995;71:244–5.
- 8. Sharma S, Jagdev S, Coleman R et al. Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexateinduced peritonitis Br J Cancer 1999;81:1037–41.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Klinik Tıp Bilimleri
Bölüm
Derleme
Yazarlar
Özgür Yılmaz
Bu kişi benim
Türkiye
Tamer Altındağ
Bu kişi benim
Türkiye
Burcu Artunç Ülkümen
Bu kişi benim
Türkiye
Halil Gürsoy Pala
*
Türkiye
Yayımlanma Tarihi
1 Aralık 2017
Gönderilme Tarihi
30 Eylül 2016
Kabul Tarihi
23 Ocak 2017
Yayımlandığı Sayı
Yıl 2017 Cilt: 7 Sayı: 3